Disease, Disability, and Injury Prevention and Control; Special Emphasis Panel (SEP): Initial Review, 16335-16336 [2014-06453]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 57 / Tuesday, March 25, 2014 / Notices
emcdonald on DSK67QTVN1PROD with NOTICES
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is a reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee on Procedures
Review was established to aid the ABRWH in
carrying out its duty to advise the Secretary,
HHS, on dose reconstructions. The
Subcommittee on Procedures Review is
responsible for overseeing, tracking, and
participating in the reviews of all procedures
used in the dose reconstruction process by
the NIOSH Division of Compensation
Analysis and Support (DCAS) and its dose
reconstruction contractor (Oak Ridge
Associated Universities—ORAU).
Matters For Discussion: The agenda for the
Subcommittee meeting includes: discussion
of procedures in the following ORAU and
DCAS technical documents: ORAU Team
Technical Information Bulletin (OTIB)0034
(‘‘Internal Dose Coworker Data for X–10’’),
OTIB 0054 (‘‘Fission and Activation Product
Assignment for Internal Dose-Related Gross
Beta and Gross Gamma Analyses’’), OTIB
0083 (‘‘Dissolution Models for Insoluble
Plutonium 238’’), Program Evaluation Report
(PER) 011 (‘‘K–25 [Technical Basis
Document] TBD and TIB Revisions’’), PER
020 (‘‘Blockson TBD Revision’’), PER 031
(‘‘Y–12 TBD Revisions’’), PER 033
(‘‘Reduction Pilot Plant TBD Revision’’), PER
038 (‘‘Hooker Electrochemical TBD
Revisions’’); Update on Review of ORAU
Team Report 0053 (‘‘Stratified Co-Worker
Sets’’); discussion of estimating radiation
doses associated with localized skin
exposures to uranium at Atomic Weapons
Employer facilities; and a continuation of the
comment-resolution process for other dose
reconstruction procedures under review by
the Subcommittee.
The agenda is subject to change as
priorities dictate.
Contact Person For More Information:
Theodore Katz, Designated Federal Officer,
NIOSH, CDC, 1600 Clifton Road NE.,
Mailstop E–20, Atlanta Georgia 30333,
Telephone (513) 533–6800, Toll Free
1(800)CDC–INFO, Email ocas@cdc.gov. The
Director, Management Analysis and Services
Office, has been delegated the authority to
sign Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
16335
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control; Special
Emphasis Panel (SEP): Initial Review
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Research Approaches to
Improve the Care and Outcomes of
People Living with Spina Bifida, FOA
DD14–002, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
The meeting announced below
concerns A Creutzfeldt-Jakob Disease
(CJD) Lookback Study: Assessing the
Risk of Blood Borne Transmission of
Classic Forms of Creutzfeldt-Jakob
Disease, Funding Opportunity
Announcement (FOA) CK14–005, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Times and Dates: 9:00 a.m.–6:00 p.m.,
April 14, 2014 (Closed).
9:00 a.m.–6:00 p.m., April 15, 2014
(Closed).
9:00 a.m.–6:00 p.m., April 16, 2014
(Closed).
9:00 a.m.–6:00 p.m., April 17, 2014
(Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters For Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Research Approaches to
Improve the Care and Outcomes of People
Living with Spina Bifida, FOA DD14–002,
initial review.’’
Contact Person For More Information: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F–80, Atlanta, Georgia 30341,
Telephone: (770) 488–3585, EEO6@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Time And Date: 2:00 p.m.–3:30 p.m., EST,
April 15, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters For Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘A Creutzfeldt-Jakob Disease
(CJD) Lookback Study: Assessing the Risk of
Blood Borne Transmission of Classic Forms
of Creutzfeldt-Jakob Disease, FOA CK14–005,
initial review.’’
Contact Person For More Information:
Gregory Anderson, M.S., M.P.H., Scientific
Review Officer, CDC, 1600 Clifton Road NE.,
Mailstop E60, Atlanta, Georgia 30333,
Telephone: (404) 718–8833.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–06451 Filed 3–24–14; 8:45 am]
BILLING CODE 4163–18–P
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–06450 Filed 3–24–14; 8:45 am]
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
[FR Doc. 2014–06452 Filed 3–24–14; 8:45 am]
Disease, Disability, and Injury
Prevention and Control; Special
Emphasis Panel (SEP): Initial Review
BILLING CODE 4163–18–P
The meeting announced below
concerns Grants for Injury Control
VerDate Mar<15>2010
18:16 Mar 24, 2014
Jkt 232001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
E:\FR\FM\25MRN1.SGM
25MRN1
16336
Federal Register / Vol. 79, No. 57 / Tuesday, March 25, 2014 / Notices
Research Centers (Panel 3), Funding
Opportunity Announcement (FOA)
CE14–001, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 9:00 a.m.–6:00 p.m. EST,
April 17–18, 2014 (Closed).
Place: Georgian Terrace, 659 Peachtree
Road NE., Room 4, Atlanta, Georgia 30308.
This meeting will also be held by
teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters For Discussion: The meeting will
include the initial review, discussion, and
evaluation of developmental center
applications received in response to ‘‘Grants
for Injury Control Research Centers, Panel 3,
FOA CE14–001’’.
Contact Person For More Information: Jane
Suen, Dr.P.H., M.S., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F63, Atlanta, Georgia 30341–3724,
Telephone (770) 488–4281.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–06453 Filed 3–24–14; 8:45 am]
BILLING CODE 4163–18–P
Status: Open to public, limited only by the
space available. The meeting room
accommodates approximately 50 people.
Purpose: This committee is charged with
providing advice to the Secretary,
Department of Health and Human Services;
the Director, CDC; and the Director, NIOSH,
on priorities in mine safety and health
research, including grants and contracts for
such research, 30 U.S.C. 812(b)(2), Section
102(b)(2).
Matters for Discussion: The meeting will
focus on mining safety and health research
projects and outcomes, including program
imperatives, e.g. respirable dust control,
oxygen supply, explosion prevention, metal
mine ground control, and health and safety
management systems; and select project startups including source control of float dust,
improving self-escape and a refuge chamber
demonstration task. The meeting will also
include updates from the National Personal
Protective Technology Laboratory and the
Division of Respiratory Disease Studies; and
continuation of the discussions on
Implementation of the National Academies
Recommendations for continuous
improvement of the mining research
program.
Agenda items are subject to change as
priorities dictate.
Contact Person For More Information:
Jeffery L. Kohler, Ph.D., Designated Federal
Officer, MSHRAC, NIOSH, CDC, 626
Cochrans Mill Road, Mailstop P05,
Pittsburgh, Pennsylvania 15236, Telephone
(412) 386–5301, Fax (412) 386–5300. The
Director, Management Analysis and Services
Office, has been delegated the authority to
sign Federal Register Notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2014–06454 Filed 3–24–14; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Mine Safety and Health Research
Advisory Committee, National Institute
for Occupational Safety and Health
(MSHRAC, NIOSH)
emcdonald on DSK67QTVN1PROD with NOTICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates: 8:30 a.m.–5:30 p.m.,
April 9, 2014; 8:30 a.m.–3:00 p.m., April 10,
2014.
Place: DoubleTree by Hilton, Pittsburgh
Airport, 8402 University Boulevard, Moon
Township, Pennsylvania 15108 Telephone:
(412) 329–1400, Fax: (412) 329–1410.
VerDate Mar<15>2010
18:16 Mar 24, 2014
Jkt 232001
Board of Scientific Counselors, Office
of Public Health Preparedness and
Response, Board of Scientific
Counselors (BSC OPHPR)
Correction: This notice was published
in the Federal Register on March 11,
2014, Volume 79, Number 47, page
13655. The meeting date previously
published should read: 10:00 a.m.–5:15
p.m., EST, April 7, 2014 and 8:00 a.m.–
3:15 p.m., EST, April 8, 2014.
Contact Person For More Information:
Marquita Black, Executive Assistant,
Office of Science and Public Health
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Practice, Centers for Disease Control and
Prevention, 1600 Clifton Road NE.,
Mailstop D–44, Atlanta, Georgia 30333,
Telephone: (404) 639–7325; Facsimile:
(404) 639–7977; Email:
OPHPR.BSC.Questions@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–06449 Filed 3–24–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–216–94 and
CMS–10224]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
any of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
E:\FR\FM\25MRN1.SGM
25MRN1
]]>Agencies
[Federal Register Volume 79, Number 57 (Tuesday, March 25, 2014)]
[Notices]
[Pages 16335-16336]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-06453]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control; Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Grants for Injury Control
[[Page 16336]]
Research Centers (Panel 3), Funding Opportunity Announcement (FOA)
CE14-001, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 9:00 a.m.-6:00 p.m. EST, April 17-18, 2014
(Closed).
Place: Georgian Terrace, 659 Peachtree Road NE., Room 4,
Atlanta, Georgia 30308. This meeting will also be held by
teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters For Discussion: The meeting will include the initial
review, discussion, and evaluation of developmental center
applications received in response to ``Grants for Injury Control
Research Centers, Panel 3, FOA CE14-001''.
Contact Person For More Information: Jane Suen, Dr.P.H., M.S.,
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop
F63, Atlanta, Georgia 30341-3724, Telephone (770) 488-4281.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2014-06453 Filed 3-24-14; 8:45 am]
BILLING CODE 4163-18-P
